Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Mar 2, 2026
Reporting period
Not applicable
Filed with the SEC
Mar 4, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001659075-26-000002
Filed / recorded
Mar 4, 2026, 10:00 PM UTC
Added to OQRO
Oct 2, 2026, 12:27 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
Elevance Health, Inc.
Issuer CIK
1156039
Ticker
ELV
Reporting person
Ronald W Penczek
Relationship
Officer
Officer title
CAO & Controller
Security
Employee Stock Option (Right to Buy)
Table
Derivative (Table II)
Transaction date
Mar 2, 2026
Transaction code
A
Shares / units
1,677
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
1,677
Ownership form
Direct
Amendment
No
Footnotes from the filing
The option represents a right to purchase a total of 1,677 shares, and is exercisable in three annual installments, each installment of 559 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.